Literature DB >> 31273715

Behavior Model for Assessing Decline in Executive Function During Aging and Neurodegenerative Diseases.

Brittney Yegla1, Thomas C Foster1, Ashok Kumar2,3.   

Abstract

Executive dysfunction is a characteristic of several psychiatric and neurodegenerative diseases. Interestingly, executive function, which is mediated by the prefrontal cortex (PFC), commonly declines during aging. The attentional set-shifting task (AST) is commonly and extensively used to assess executive function in rodents, primates, and humans. When properly employed, this task can behaviorally assess attention, response inhibition, and cognitive flexibility. The following section uses research on age-related decline in executive function to demonstrate the methods employed and highlight areas that can confound a study if not employed properly.

Entities:  

Keywords:  Aging; Attention; Attentional set-shifting task; Cognitive flexibility; Executive function; Neurodegenerative diseases; Prefrontal cortex

Mesh:

Year:  2019        PMID: 31273715      PMCID: PMC8223146          DOI: 10.1007/978-1-4939-9554-7_26

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  30 in total

1.  Lesions of the orbital prefrontal cortex impair the formation of attentional set in rats.

Authors:  E Alexander Chase; David S Tait; Verity J Brown
Journal:  Eur J Neurosci       Date:  2012-06-04       Impact factor: 3.386

2.  A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive functioning and cognitive aging. Cambridge Neuropsychological Test Automated Battery.

Authors:  T W Robbins; M James; A M Owen; B J Sahakian; A D Lawrence; L McInnes; P M Rabbitt
Journal:  J Int Neuropsychol Soc       Date:  1998-09       Impact factor: 2.892

3.  Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset.

Authors:  R Dias; T W Robbins; A C Roberts
Journal:  Behav Neurosci       Date:  1996-10       Impact factor: 1.912

4.  Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting.

Authors:  Stan B Floresco; Orsolya Magyar; Sarvin Ghods-Sharifi; Claudia Vexelman; Maric T L Tse
Journal:  Neuropsychopharmacology       Date:  2006-02       Impact factor: 7.853

Review 5.  Attentional Set-Shifting Across Species.

Authors:  Verity J Brown; David S Tait
Journal:  Curr Top Behav Neurosci       Date:  2016

6.  Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia.

Authors:  Alice Egerton; Lee Reid; Clare E McKerchar; Brian J Morris; Judith A Pratt
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

7.  Lesions of the dorsomedial striatum impair formation of attentional set in rats.

Authors:  Hanna S Lindgren; Robin Wickens; David S Tait; Verity J Brown; Stephen B Dunnett
Journal:  Neuropharmacology       Date:  2013-04-11       Impact factor: 5.250

8.  Sustained Attention Across the Life Span in a Sample of 10,000: Dissociating Ability and Strategy.

Authors:  Francesca C Fortenbaugh; Joseph DeGutis; Laura Germine; Jeremy B Wilmer; Mallory Grosso; Kathryn Russo; Michael Esterman
Journal:  Psychol Sci       Date:  2015-08-07

9.  Noradrenergic, but not cholinergic, deafferentation of prefrontal cortex impairs attentional set-shifting.

Authors:  J McGaughy; R S Ross; H Eichenbaum
Journal:  Neuroscience       Date:  2008-02-19       Impact factor: 3.590

10.  Inactivation of the medial prefrontal cortex of the rat impairs strategy set-shifting, but not reversal learning, using a novel, automated procedure.

Authors:  Stan B Floresco; Annie E Block; Maric T L Tse
Journal:  Behav Brain Res       Date:  2008-02-15       Impact factor: 3.332

View more
  1 in total

1.  Selection of Mice for Object Permanence Cognitive Task Solution.

Authors:  Olga Viktorovna Perepelkina; Inga Igorevna Poletaeva
Journal:  Neurol Int       Date:  2022-08-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.